Enveric Biosciences Earnings Estimate
| ENVB Stock | USD 2.95 0.04 1.37% |
Enveric Biosciences Earnings Estimation Breakdown
The calculation of Enveric Biosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Enveric Biosciences is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Enveric Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
Enveric Biosciences Earnings Projection Consensus
Suppose the current estimates of Enveric Biosciences' value are higher than the current market price of the Enveric Biosciences stock. In this case, investors may conclude that Enveric Biosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Enveric Biosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2022 | Current EPS (TTM) | |
| 1 | 36.62% | -2.47 | 0.0 | -119.64 |
Enveric Biosciences Earnings per Share Projection vs Actual
Actual Earning per Share of Enveric Biosciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Enveric Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Enveric Biosciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Enveric Biosciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Enveric Biosciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Enveric Biosciences should always be considered in relation to other companies to make a more educated investment decision.Enveric Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Enveric Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-14 | 2025-09-30 | -0.35 | -10.81 | -10.46 | 2988 | ||
2025-08-14 | 2025-06-30 | -0.35 | -11.65 | -11.3 | 3228 | ||
2025-05-13 | 2025-03-31 | -0.4 | -4.8168 | -4.4168 | 1104 | ||
2025-03-28 | 2024-12-31 | -0.23 | -0.17 | 0.06 | 26 | ||
2024-11-14 | 2024-09-30 | -7.8 | -3.6 | 4.2 | 53 | ||
2024-08-12 | 2024-06-30 | -0.55 | -0.25 | 0.3 | 54 | ||
2024-05-15 | 2024-03-31 | -0.77 | -0.42 | 0.35 | 45 | ||
2024-03-26 | 2023-12-31 | -1.54 | -1.47 | 0.07 | 4 | ||
2023-11-13 | 2023-09-30 | -2.09 | -1.3 | 0.79 | 37 | ||
2023-08-11 | 2023-06-30 | -0.65 | -3.04 | -2.39 | 367 | ||
2023-05-15 | 2023-03-31 | -2.23 | -4.235 | -2.005 | 89 | ||
2022-11-14 | 2022-09-30 | -4 | -2.47 | 1.53 | 38 | ||
2022-08-12 | 2022-06-30 | -3.83 | -2.73 | 1.1 | 28 | ||
2022-05-13 | 2022-03-31 | -6 | -5.35 | 0.65 | 10 | ||
2022-03-31 | 2021-12-31 | -8 | -89.0 | -81.0 | 1012 | ||
2021-11-15 | 2021-09-30 | -8 | -6.0 | 2.0 | 25 | ||
2021-08-13 | 2021-06-30 | -8.75 | -2.0 | 6.75 | 77 | ||
2021-05-17 | 2021-03-31 | -9.5 | -0.04 | 9.46 | 99 | ||
2019-11-08 | 2019-09-30 | -5 | -0.025 | 4.975 | 99 | ||
2019-08-14 | 2019-06-30 | -150 | -0.75 | 149.25 | 99 | ||
2019-03-26 | 2018-12-31 | -200 | -1600.0 | -1400.0 | 700 | ||
2018-11-14 | 2018-09-30 | -250 | -300.0 | -50.0 | 20 | ||
2018-08-14 | 2018-06-30 | -400 | -300.0 | 100.0 | 25 | ||
2018-05-15 | 2018-03-31 | -0.08 | -2.25 | -2.17 | 2712 |
About Enveric Biosciences Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Enveric Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Enveric Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Enveric Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -95.5 M | -90.7 M | |
| Earnings Yield | (4.07) | (3.87) | |
| Price Earnings Ratio | (0.32) | (0.34) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enveric Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. Projected growth potential of Enveric fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enveric Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (119.64) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Understanding Enveric Biosciences requires distinguishing between market price and book value, where the latter reflects Enveric's accounting equity. The concept of intrinsic value - what Enveric Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Enveric Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Enveric Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enveric Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Enveric Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.